You are here

  • Home
  • Archive
  • Volume 62, Issue 12
  • Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense

Citation Tools

Article menu
Download PDFPDF
Extended report
Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
van Vollenhoven R, Harju A, Brannemark S, et al
Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense
Annals of the Rheumatic Diseases 2003;62:1195-1198.